In March 2022, the chief executive officer (CEO) of Auchan Retail Group (Auchan), a top French retailer, faced a serious dilemma. As head of a €30 billion, privately held company, the CEO had to choose between staying the course and leaving Russia, one of Auchan's top three markets, in the aftermath of the business turnaround and explosive geopolitical tensions that followed within two weeks of the Russian invasion of Ukraine. Public backlash had already forced more than 300 companies to exit or scale down their operations in this large emerging market. In this context, as he prepared for an interview with a popular French newspaper, the CEO had to decide how to best to address this dilemma: should Auchan follow the crowd or stay the course?
In March 2022, the chief executive officer (CEO) of Auchan Retail Group (Auchan), a top French retailer, faced a serious dilemma. As head of a €30 billion, privately held company, the CEO had to choose between staying the course and leaving Russia, one of Auchan’s top three markets, in the aftermath of the business turnaround and explosive geopolitical tensions that followed within two weeks of the Russian invasion of Ukraine. Public backlash had already forced more than 300 companies to exit or scale down their operations in this large emerging market. In this context, as he prepared for an interview with a popular French newspaper, the CEO had to decide how to best to address this dilemma: should Auchan follow the crowd or stay the course?
In May 2022, the chief executive officer (CEO) of Pfizer Inc. (Pfizer), Albert Bourla, announced an initiative called “An Accord for a Healthier World” to supply less-developed countries with the company’s COVID-19 vaccine Comirnaty and the oral antiviral drug Paxlovid. The program sought to reach 1.2 billion people in 45 countries with a focus on treating diseases that disproportionately affected low-income countries. The initiative was part of the company’s goal to reduce the number of people around the world who could not afford their medicines by 50 per cent. Bourla’s plan was to reach that goal by 2023.<br><br>The move was in response to criticism that Pfizer was not doing enough to get vaccines to people in less-developed countries. The CEO acknowledged the challenges of distribution, such as poor infrastructure, misinformation, and corruption and stated that solutions should address these underlying problems, rather than focusing on the cost of vaccines. He also stated that a vaccine patent waiver would not be effective because other countries did not have the necessary infrastructure or knowledge to safely produce high-quality vaccines. The waiver would also set a precedent for future endeavours, potentially making manufacturers reluctant to develop new treatments. However, how could Pfizer effectively communicate its efforts to address global health inequities?
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021. The company, based in Sacramento CA, was a compounding pharmacy serving Total Parenteral Nutrition ("TPN") patients nationwide. Holbrook and Pulsipher generally believed it was best to not make big changes during the first year after an acquisition. However, two competitors had recently exited their TPN businesses, creating an opportunity for Nutrishare to add a significant number of new clients. This opportunity would grow the business by about a quarter which would immediately reverse the stagnant client count and have a substantial impact on value. However, it would also add stresses on the Company to serve the new clients.
The case is about Birkenstock, the renowned German shoemaker, and two turning points in its 248-year history: the owner's decision to bring in a professional CEO in 2012, and the sale of a majority stake to a French-American investment firm in 2021. Founded by German cobbler Johann Adam Birkenstock in 1774, the company had always been 100% owned by the same family and managed by a single descendant, a tradition upended in 2002 when Carl Birkenstock, the CEO and owner, handed over his shares and job to his three sons. Ten years later, unable to agree on strategy and with tensions rising in the family, the brothers decided to bring in a professional CEO to put the struggling shoemaker back on its feet. Under the new manager, sales of Birkenstock sandals increased to such an extent that the company attracted the interest of investors. Meanwhile, one of the sons sold his shares to his two brothers, who then instructed the CEO to find a buyer. Offered the opportunity to become billionaires overnight, they sold the company to a private equity firm backed by the world's largest fortune and owner of LVMH, Bernard Arnault.
A survey of more than 1,600 Bed Bath & Beyond shoppers reveals why a business recovery strategy set in motion by a new management team in 2019 failed: The BB&B leadership team's focus on cost cutting overlooked the importance of creating value for customers. The story of the retailer's bankruptcy is a cautionary tale for other businesses that are struggling to adapt and at risk of losing sight of customer value creation amid increased competition in a changing market.
This note introduces some fundamental concepts regarding Indigenous peoples and their relationships to the land in Canada. It revisits injustices experienced by Indigenous peoples since the arrival of European settlers and investigates attempts at addressing those injustices. In the context of this note, “Indigenous” refers to the original inhabitants of North America and their descendants. Indigenous peoples in Canada describes three distinct groups, the First Nations, Métis, and Inuit, all of which are individually discussed later in this note. This note is based on a literature review of academic and governmental information sources.
In May 2022, the chief executive officer (CEO) of Pfizer Inc. (Pfizer), Albert Bourla, announced an initiative called "An Accord for a Healthier World" to supply less-developed countries with the company's COVID-19 vaccine Comirnaty and the oral antiviral drug Paxlovid. The program sought to reach 1.2 billion people in 45 countries with a focus on treating diseases that disproportionately affected low-income countries. The initiative was part of the company's goal to reduce the number of people around the world who could not afford their medicines by 50 per cent. Bourla's plan was to reach that goal by 2023. The move was in response to criticism that Pfizer was not doing enough to get vaccines to people in less-developed countries. The CEO acknowledged the challenges of distribution, such as poor infrastructure, misinformation, and corruption and stated that solutions should address these underlying problems, rather than focusing on the cost of vaccines. He also stated that a vaccine patent waiver would not be effective because other countries did not have the necessary infrastructure or knowledge to safely produce high-quality vaccines. The waiver would also set a precedent for future endeavours, potentially making manufacturers reluctant to develop new treatments. However, how could Pfizer effectively communicate its efforts to address global health inequities?
This case provides an overview of the venture debt industry with a focus on WTI, a leading venture debt provider. The case follows Maurice Werdegar, the Chairman of WTI, as he considers offering a new loan and amending an existing loan.
Deepinder Goyal and Pankaj Chaddah co-founded Zomato as a food discovery platform that listed menus from restaurants in the Delhi National Capital Region (Delhi-NCR). Zomato quickly gained popularity and expanded its services to multiple cities in India and abroad. In 2015, Zomato shifted its focus from providing only restaurant discovery services to exploring new business initiatives. One such initiative was Zomaland, which was conceptualised as a food carnival that combined three elements-fun activities, lip-smacking food and entertainment. Zomato organised two seasons of Zomaland in various cities and formats in 2019 and 2020. However, because of the outbreak of the COVID-19 pandemic, the company was forced to suspend Zomaland operations. As the economy gradually returned to normal in 2022, Zomato had to reappraise the future of Zomaland and its synergy with other services offered by Zomato.
What separates digital finance leaders from the laggards? How can CFOs better use advanced analytics to their advantage? This article offers a framework to help CFOs assess the finance office's current level of data sophistication and discusses the key areas finance teams should focus on to improve their analytics capabilities.
This case is about organizational change and technology. It follows the efforts of one physician as they try to move their department past using the pager, a device that persisted in American medicine despite having long been outdated by superior communication technology. The case reveals the complex organizational factors that have made this persistence possible, such as differing interdepartmental priorities, the perceived benefits of simple technology, and the potential drawbacks of applying typical continuous improvement approaches to technology change. Ultimately the physician in the case is not able to rid their department of the pager, despite pursuing a thorough continuous improvement effort and piloting a viable alternative; the case ends with the physician having an opportunity to try again and asks students to assess whether doing so is wise. The case can be used in class to help students apply the general concepts of organizational change to the particular context of technology, discuss the forces of stasis and change in medicine, and to familiarize students with the uses and limits of continuous improvement methods.
This case describes efforts to promote racial equity in healthcare financing from the perspective of one public health organization, Community Care Cooperative (C3). C3 is a Medicaid Accountable Care Organization-i.e., an organization set up to manage payment from Medicaid, a public health insurance option for low-income people. The case describes C3's approach to addressing racial equity from two vantage points: first, its programmatic efforts to channel financing into community health centers that serve large proportions of Black, Indigenous, People of Color (BIPOC), and second, its efforts to address racial equity within its own internal operations (e.g., through altering hiring and promotion processes). The case can be used to help students understand structural issues pertaining to race in healthcare delivery and financing, to introduce students to the basics of payment systems in healthcare, and/or to highlight how organizations can work internally to address racial equity.
Companies increasingly consider external contributors to be a part of their workforce. But these work arrangements can introduce complex management challenges, given external workers' relative autonomy and a lack of coordinated management of internal and external talent. The authors describe a framework they have developed, based on three years of research conducted by MIT Sloan Management Review and Deloitte, to help leaders manage or orchestrate these workforce ecosystems.
On 7 October 2020, the employees of Raya, an Egyptian holding company, received an email that sent shockwaves across the entire firm. The board had just announced that Medhat Khalil, Raya's co-founder, primary shareholder and long-serving CEO, would be stepping down after 21 years, leaving the position to his son Ahmed Khalil, who was just under 40 years old. Every one of Raya Holding's 13,000 employees was trying to guess how this would impact the company's operations and shape its future. On that day, Ahmed was in his Cairo office, and there was little time to celebrate. He had joined Raya back in 2013, and this moment was the zenith of his career. Ahmed had watched his father develop the company into a successfully diversified conglomerate and the leadership bar was set very high. Reflecting on the milestones achieved under his father's leadership, Ahmed wondered whether the company needed to transform itself to sustain the growth it had demonstrated in the past. Specifically, he questioned whether the holding's current structure was still the best way to sustain growth. If that was not the case, what changes were required? Ahmed was going to spend the next few months finding an answer to this critical question. He was fully aware he had one chance to gain an in-depth understanding of what was really required to future-proof Raya, and - if change proved necessary - to get the transformation right.
Yukimi Daifuku was an ice cream that had been sold exclusively during the winter season in Japan for almost four decades. Lotte Co., Ltd. (Lotte) entered the ice cream market thirty years after its major competitors, so the company strategically targeted the ice cream off-season, when other producers were not promoting their products. Lotte successfully grew the product’s sales, and Yukimi Daifuku became an iconic winter ice cream in Japan. However, the external environment surrounding Yukimi Daifuku had undergone significant changes, and in 2018, Lotte decided to sell the product year-round in order to boost availability and sales. Yukimi Daifuku saw sales momentum in 2019, but growth stalled in 2020. Without the benefits of its historical (and iconic) off-season position, Yukimi Daifuku faced the challenge of thriving in the competitive Japanese ice cream market. In addition, the patent on the product development process of Yukimi Daifuku was set to expire in March 2021. Without the iconic winter ice cream positioning and patent—the two key factors for their forty-year success—what were the next steps needed for the Yukimi Daifuku Branding Division for the product?